Watch Out For Higher Treasury Yields at 5.0%

Ahead of the U.S. Treasury auction, yields continued to climb. Markets traded lower on Tuesday, while Asia-Pacific markets opened lower in Wednesday morning trade. Samsung (SSNLF) managed to trade slightly higher, despite issuing a profit forecast for the fourth quarter that did not meet expectations. High U.S. treasury yields compete for investor money. Instead of…

Read More

GeneDX Slides on Asserting Industry Leadership Role

GeneDx (NASDAQ: WGS) shares fell Wednesday. The company, a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through understanding gene-disease relationships, contributing to more than 85 peer-reviewed publications in 2024. These contributions, added to GeneDx’s years of dedicated research efforts, influenced the broadening of phenotypes, the discovery…

Read More

IGC Gains on Word of Alzheimer’s Treatment

IGC Pharma, Inc. (NYSE:IGC) shares made small progress Wednesday, on word its ongoing Phase 2 trial for agitation in Alzheimer’s disease has been officially named CALMA (Calming Agitation in Alzheimer’s). The Potomac, Md.-based company says its trial’s new identity reflects its mission to address agitation, a syndrome affecting up to 76% of the 55 million…

Read More

Unifirst Jump on Q1 Numbers

UniFirst Corporation (NYSE: UNF) shares sprang up Wednesday, after releasing results for its first quarter ended November 30, 2024 as compared to the corresponding period in the prior fiscal year: The Wilmington, Mass.-based company reported consolidated revenues for the first quarter increased 1.9% to $604.9 million; operating income was $55.5 million, an increase of 4.5%….

Read More

Big Movers: Moderna Rose, Palantir, and Applovin Fell

Investors speculated on Covid vaccine firms. Despite the seasonal strength for flu-related vaccines ending, Moderna (MRNA) gained 11.65% to close at $47.53. Pfizer (PFE), BioNTech (BNTX), Arcturus Therapeutics (ARCT), and Novavax (NVAX) rallied. The Centers for Disease Control and Prevention announced respiratory illness data in the last week. Covid infections are more frequent alongside a…

Read More